These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 31313215)

  • 1. Evaluation of serum cytokine and chemokine levels in dermatitis herpetiformis: a systematic review and meta-analysis.
    Kowalski EH; Kneibner D; Patel A; Kridin K; Amber KT
    Immunol Res; 2019 Jun; 67(2-3):265-266. PubMed ID: 31313215
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased Serum Levels of Th2-type Cytokines and Eotaxin in Fibrillar-type Dermatitis Herpetiformis.
    Makino T; Yoshihisa Y; Mizawa M; Tsutsui K; Nishijima C; Inaoki M; Shimizu T
    Acta Derm Venereol; 2017 May; 97(5):642-643. PubMed ID: 27983746
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum eosinophil cationic protein, myeloperoxidase, tryptase, eotaxin and Th2-L-like cytokines in Dermatitis herpetiformis.
    Caproni M; Cardinali C; D'Agata A; Selvaggi W; Fabbri P
    Int Arch Allergy Immunol; 2002 May; 128(1):67-72. PubMed ID: 12037403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical pearl: Using tissue transglutaminase antibodies to diagnose dermatitis herpetiformis.
    Desai AM; Krishnan RS; Hsu S
    J Am Acad Dermatol; 2005 Nov; 53(5):867-8. PubMed ID: 16243141
    [No Abstract]   [Full Text] [Related]  

  • 5. Investigations into the etiology of dermatitis herpetiformis. 1. The effects of serum from dermatitis herpetiformis cases on the spreading property of hvaluronidase.
    ALEXANDER JO
    J Invest Dermatol; 1961 Jul; 37():39-49. PubMed ID: 13682345
    [No Abstract]   [Full Text] [Related]  

  • 6. Could anti-glycan antibodies be useful in dermatitis herpetiformis?
    Gasparini G; Cozzani E; Caproni M; Antiga E; Signori A; Parodi A
    Eur J Dermatol; 2019 Jun; 29(3):322-323. PubMed ID: 31251212
    [No Abstract]   [Full Text] [Related]  

  • 7. Methods for diagnosing dermatitis herpetiformis.
    Beutner EH; Plunkett RW
    J Am Acad Dermatol; 2006 Dec; 55(6):1112-3. PubMed ID: 17110230
    [No Abstract]   [Full Text] [Related]  

  • 8. Criteria for the diagnosis of dermatitis herpetiformis.
    Fry L; Seal PP
    Proc R Soc Med; 1973 Aug; 66(8):749-50. PubMed ID: 4582196
    [No Abstract]   [Full Text] [Related]  

  • 9. Asymptomatic anemia in three men with dermatitis herpetiformis.
    Denman SL; Freeman NJ
    Hosp Pract (Off Ed); 1992 Apr; 27(4):187, 189-90. PubMed ID: 1560069
    [No Abstract]   [Full Text] [Related]  

  • 10. Paper electrophoretic analysis of serum glycoproteins in dermatitis herpetiformis.
    ALEXANDER JO
    J Invest Dermatol; 1962 May; 38():255-9. PubMed ID: 13860339
    [No Abstract]   [Full Text] [Related]  

  • 11. Endomysium and antigliadin antibodies in dermatitis herpetiformis and other bullous diseases.
    Economidou J; Avgerinou G; Tsiroyianni A; Stavropoulos P; Vareltzidis A; Katsambas A
    J Eur Acad Dermatol Venereol; 1998 Sep; 11(2):184-5. PubMed ID: 9784051
    [No Abstract]   [Full Text] [Related]  

  • 12. High leucocytosis (leukaemoid reactions) in dermatitis herpetiformis.
    EVEN-PAZ Z; SAGHER F
    Br J Dermatol; 1959 Oct; 71():325-34. PubMed ID: 13821044
    [No Abstract]   [Full Text] [Related]  

  • 13. Transglutaminases as diagnostically relevant autoantigens in patients with gluten sensitivity.
    Heil PM; Volc-Platzer B; Karlhofer F; Gebhart W; Huber WD; Benesch T; Vogelsang H; Stingl G
    J Dtsch Dermatol Ges; 2005 Dec; 3(12):974-8. PubMed ID: 16405713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dapsone and severe hypoalbuminaemia in dermatitis herpetiformis.
    Cowan RE; Wright JT
    Br J Dermatol; 1981 Feb; 104(2):201-4. PubMed ID: 7213552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to tissue transglutaminase as serologic markers in patients with dermatitis herpetiformis.
    Dieterich W; Laag E; Bruckner-Tuderman L; Reunala T; Kárpáti S; Zágoni T; Riecken EO; Schuppan D
    J Invest Dermatol; 1999 Jul; 113(1):133-6. PubMed ID: 10417632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guidelines for the diagnosis and treatment of dermatitis herpetiformis.
    Caproni M; Antiga E; Melani L; Fabbri P;
    J Eur Acad Dermatol Venereol; 2009 Jun; 23(6):633-8. PubMed ID: 19470076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphonuclear leukocyte chemotaxis in dermatitis herpetiformis.
    Esca SA; Pehamberger H; Silny W; Holubar K
    Acta Derm Venereol; 1981; 61(1):61-3. PubMed ID: 6164218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognosis of herpetiform dermatitis in children.
    SØBYE P
    Acta Derm Venereol; 1948; 28(3):262-9. PubMed ID: 18891985
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of ibuprofen on serum dapsone levels and disease activity in dermatitis herpetiformis.
    Smith JB; Fowler JB; Zone JJ
    Arch Dermatol; 1994 Feb; 130(2):257-9. PubMed ID: 8304772
    [No Abstract]   [Full Text] [Related]  

  • 20. Detection of gluten in human sera by an enzyme immunoassay: comparison of dermatitis herpetiformis and celiac disease patients with normal controls.
    Lane AT; Huff JC; Weston WL
    J Invest Dermatol; 1982 Sep; 79(3):186-9. PubMed ID: 7050253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.